Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Blackrock
BLK
$183B
| $78.3M | 0.02% |
128,516
+1,276
| +1% | +$831K |
|
702
Antero Resources
AR
$11.3B
| $78.2M | 0.02% |
2,551,370
+256,062
| +11% | +$9.37M |
|
703
PUT
Sherwin-Williams
SHW
$87.8B
| $78.1M | 0.02% |
348,900
+215,100
| +161% | +$55.2M |
|
704
Corpay
CPAY
$27.9B
| $78M | 0.02% |
371,460
-292,641
| -44% | -$69.7M |
|
705
PUT
Alcoa
AA
$13.1B
| $78M | 0.02% |
1,711,100
-144,700
| -8% | -$9.39M |
|
706
CALL
Atlassian
TEAM
$42.1B
| $77.8M | 0.02% |
415,200
-211,600
| -34% | -$45.2M |
|
|
SCHW
707
CALL
Charles Schwab
SCHW
$190B
| $77.8M | 0.02% |
1,231,500
+229,800
| +23% | +$15.8M |
|
708
PUT
Hershey
HSY
$37.4B
| $77.7M | 0.02% |
360,900
+260,100
| +258% | +$56.7M |
|
709
PUT
eBay
EBAY
$46.5B
| $77.6M | 0.02% |
1,861,500
+509,600
| +38% | +$24.8M |
|
710
PUT
Shell
SHEL
$248B
| $77.5M | 0.02% |
1,481,200
+2,700
| +0.2% | +$152K |
|
711
PUT
State Street Materials Select Sector SPDR ETF
XLB
$8.57B
| $77.3M | 0.02% |
2,100,400
+1,284,800
| +158% | +$53.8M |
|
712
Albemarle
ALB
$15.4B
| $76.8M | 0.02% |
367,678
+365,579
| +17,417% | +$81.6M |
|
713
CALL
Stryker
SYK
$131B
| $76.4M | 0.02% |
384,100
+24,700
| +7% | +$5.8M |
|
714
Olin
OLN
$2.17B
| $76.4M | 0.02% |
1,649,993
+936,765
| +131% | +$54.1M |
|
715
PUT
Kraft Heinz
KHC
$30.1B
| $76.2M | 0.02% |
1,998,700
+660,500
| +49% | +$26.4M |
|
716
CALL
Alpha Metallurgical Resources
AMR
$1.97B
| $76.2M | 0.02% |
590,100
+82,500
| +16% | +$12.5M |
|
717
Generac Holdings
GNRC
$12.8B
| $76.1M | 0.02% |
361,179
+257,276
| +248% | +$63.3M |
|
718
CALL
SolarEdge
SEDG
$1.98B
| $75.9M | 0.02% |
277,200
-21,500
| -7% | -$5.88M |
|
719
BP
BP
$110B
| $75.8M | 0.02% |
2,672,836
+1,725,660
| +182% | +$52.9M |
|
720
CALL
Vanguard S&P 500 ETF
VOO
$1.04T
| $75.6M | 0.02% |
218,000
+16,500
| +8% | +$6.22M |
|
721
Bristol-Myers Squibb
BMY
$132B
| $75.6M | 0.02% |
981,189
+584,567
| +147% | +$44.5M |
|
722
CALL
Live Nation Entertainment
LYV
$43.3B
| $75.4M | 0.02% |
913,400
-263,500
| -22% | -$25.3M |
|
723
Alibaba
BABA
$293B
| $75.4M | 0.02% |
663,172
-870,217
| -57% | -$85.3M |
|
724
BHP
BHP
$222B
| $75.1M | 0.02% |
1,335,920
+490,016
| +58% | +$30.4M |
|
725
PUT
Novavax
NVAX
$1.34B
| $74.8M | 0.02% |
1,454,900
+193,400
| +15% | +$10M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.